CAGNACCI, Angelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.369
EU - Europa 18.328
AS - Asia 7.203
SA - Sud America 79
Continente sconosciuto - Info sul continente non disponibili 25
AF - Africa 23
OC - Oceania 6
Totale 59.033
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.312
GB - Regno Unito 7.555
CN - Cina 2.779
IT - Italia 2.329
DE - Germania 2.083
SG - Singapore 2.018
SE - Svezia 1.847
UA - Ucraina 1.766
HK - Hong Kong 1.220
FI - Finlandia 900
TR - Turchia 844
BG - Bulgaria 651
RU - Federazione Russa 648
FR - Francia 208
IN - India 91
IE - Irlanda 64
BR - Brasile 57
ID - Indonesia 52
LT - Lituania 46
IR - Iran 45
CA - Canada 43
NL - Olanda 42
KR - Corea 41
ES - Italia 38
PL - Polonia 36
VN - Vietnam 26
BE - Belgio 25
EU - Europa 24
MY - Malesia 21
CH - Svizzera 18
PT - Portogallo 16
JP - Giappone 14
CL - Cile 12
DK - Danimarca 11
IL - Israele 9
GR - Grecia 8
MX - Messico 8
CZ - Repubblica Ceca 6
PH - Filippine 6
ZA - Sudafrica 6
AE - Emirati Arabi Uniti 5
BY - Bielorussia 5
LY - Libia 5
AT - Austria 4
AU - Australia 4
KZ - Kazakistan 4
RO - Romania 4
TW - Taiwan 4
VE - Venezuela 4
AR - Argentina 3
EG - Egitto 3
HU - Ungheria 3
KG - Kirghizistan 3
PK - Pakistan 3
AZ - Azerbaigian 2
BF - Burkina Faso 2
BZ - Belize 2
CO - Colombia 2
HR - Croazia 2
IQ - Iraq 2
JM - Giamaica 2
MA - Marocco 2
MC - Monaco 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SA - Arabia Saudita 2
SM - San Marino 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
HN - Honduras 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
ME - Montenegro 1
MM - Myanmar 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UZ - Uzbekistan 1
YE - Yemen 1
Totale 59.033
Salva come PNG Salva come JPEG
Città #
Southend 7.074
Jacksonville 4.026
Santa Clara 3.763
Fairfield 3.613
Dearborn 2.598
Woodbridge 2.279
Chandler 2.083
Ashburn 1.789
Houston 1.729
Singapore 1.663
Wilmington 1.442
Ann Arbor 1.232
Hong Kong 1.216
Seattle 1.207
Cambridge 1.149
Nyköping 1.120
Beijing 1.059
Princeton 757
Sofia 651
Eugene 640
Modena 604
Izmir 425
Bremen 423
San Diego 369
Helsinki 263
New York 187
Des Moines 185
Moscow 183
Milan 143
Shanghai 127
Norwalk 105
London 92
Hefei 91
Rome 83
Kunming 78
Nanjing 76
Guangzhou 66
Dublin 64
San Mateo 50
Jakarta 48
Boardman 45
Falls Church 43
Redwood City 41
Verona 40
Dongguan 35
Jinan 35
Bologna 34
Nanchang 33
Grafing 32
Augusta 30
Kraków 30
Los Angeles 26
Dong Ket 22
Fuzhou 22
Brussels 21
Saint Petersburg 21
Hebei 20
Hounslow 19
Kilburn 19
Ardabil 18
Mountain View 18
Shenyang 18
Monmouth Junction 17
Turin 17
Wuhan 17
Dallas 16
Palermo 16
Philadelphia 16
Chiswick 15
Florence 15
Leawood 15
Orsogna 15
Parma 15
Xian 15
Toronto 14
Catania 13
Genoa 12
Jinhua 12
Naples 12
San Francisco 12
Andover 11
Chicago 11
Jiaxing 11
Prescot 11
Solignano Nuovo 11
Torino 11
Tulare 11
Washington 11
Zhengzhou 11
Aosta 10
Baotou 10
Borås 10
Chongqing 10
Mumbai 10
Bari 9
Hanover 9
Indiana 9
Islington 9
San Jose 9
Southwark 9
Totale 45.841
Salva come PNG Salva come JPEG
Nome #
La melatonina aumenta la risposta delle gonadotropine al GnRH nelle donne in fase follicolare precoce, ma non nella fase luteale 285
Differenza tra forma attiva (5-MTHF) e inattiva (acido folico) di folati sulla vasodilatazione di donne in postmenopausa 256
Recommendations for contraception in women with diabetes. AMD-SIC position paper 221
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 219
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 216
Intermenstrual pelvic pain, quality of life and mood 214
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 212
Association between urinary incontinence and climacteric symptoms in postmenopausal women 210
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 206
Adenomyosis of the Extrapelvic Portion of the Round Ligament 206
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 203
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 198
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 198
Metabolic impact of combined hormonal contraceptives containing estradiol 197
Folate administration decreases oxidative status and blood pressure in postmenopausal women 196
Intensity of menstrual pain and estimated angle of uterine flexion 196
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 186
Medical and patient attitude towards vaginal atrophy: the AGATA study 185
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 185
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 184
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 183
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 183
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. 183
Efficacia del nomegestrolo acetato, derivato del 19-Nor progesterone, nel trattamento dei sintomi premestruali: uso in casi selezionati con fase luteale inadeguata 182
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 181
Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. 179
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 177
Pharmacokinetic evaluation of desogestrel as a female contraceptive 176
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. 175
Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women 175
Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive. A Patient-Preference Prospective 24-Week Pilot Study 175
Seasonal trend of acute pelvic inflammatory disease 171
Relation between body mass index and endothelium-dependent vasodilatation in healthy postmenopausal women. 170
Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease. 168
Role of melatonin in circadian rhythm at menopause 167
Prevalence of menstrual pain in young women: what is dysmenorrhea 165
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study. 165
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 165
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 165
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 164
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study. 164
Amplification of pulsatile LH secretion by exogenous melatonin in women 164
Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women 163
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 162
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy 162
Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: Comparison between oral and transdermal administration of estrogen 162
“In patient” medical abortion versus surgical abortion: patient’s satisfaction 162
Amplification of pulsatile LH secretion by exogenous melatonin in women. 160
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: A prospective one-year evaluation 160
Physiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal women. 160
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells 159
Melatonin in relation to physiology in adult humans 158
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study. 158
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study 157
Counseling on vaginal delivery of contraceptive hormones: implications for women's body knowledge and sexual health 157
Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis 156
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group* 156
Influence of melatonin and photoperiod on animal and human reproduction 155
Prolonged melatonin administration decreases nocturnal blood pressure in women 155
Dienogest mediates midkine suppression in endometriosis 155
European society of contraception statement on contraception in obese women 155
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 154
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 154
Menopausal symptoms and risk factors for cardiovascular disease in postmenopause. 153
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 150
Effect of prolonged administration of transdermal estradiol on flow-mediated endothelium-dependent and endothelium-independent vasodilation in healthy postmenopausal women. 149
Oral contraceptives and bone metabolism. 148
Regulation of the 24-hour rhythm of body temperature in menstrual cycles with spontaneous and gonadotropin-induced ovulation. 147
Estrogeni e ossido nitrico: un sinergismo. 147
Prevalence and association between objective signs and subjective symptoms of vaginal atrophy: the AGATA study 147
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 147
Anello Contraccettivo: i vantaggi della somministrazione vaginale 145
Oral contraceptives and insulin sensitivity 145
ISPOG European Consensus Statement - chronic pelvic pain in women (short version) 145
Biometrical threshold of biparietal diameter for certain fetal sex assignment by ultrasound. 145
Sympathoadrenal response of postmenopausal women prior and during prolonged administration of estradiol 144
Vaginal atrophy of women in postmenopause. Results from amulticentric observational study: The AGATA study 143
A role for melatonin in PCOS? 141
Lack of any estrogenic effect of ipriflavone in postmenopausal women. 141
The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome. 141
Influence of transdermal estradiol in the regulation of leptin levels of postmenopausal women: A double-blind, placebo-controlled study 140
Melatonin enhances cortisol levels in aged women: reversible by estrogens. 139
The effect of menopause on blood lipid and lipoprotein levels 139
Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. 139
Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism. 138
Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women 138
A comparison of the central effects of different progestins used in hormone replacement therapy 138
Effect of naloxone on body temperature in postmenopausal women with Parkinson's disease. 137
Drospirenone: dati di sicurezza a lungo termine 137
Melatonin in aged women. Possible modulation by estrogens. 137
Tibolone and estradiol plus norethisterone acetate similarly influence endothelium-dependent vasodilatation in healthy postmenopausal women 136
Potentially beneficial cardiovascular effects of melatonin administration in women. 136
Hypothermic effect of melatonin and nocturnal core body temperature decline are reduced in aged women. 135
Indirect evidence that estrogen replacement therapy stimulates nitric oxide synthase in postmenopausal women 135
Melatonin: a major regulator of the circadian rhythm of core temperature in humans. 135
Effetti dell’ HRT e SERM sulla pressione arteriosa 135
Reply to: Comment on 'Season of birth influences the timing of menopause' [7] 135
Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women 134
Bleeding profile in users of an etonogestrel sub-dermal implant: Effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population 134
Fattori implicati nel determinismo del sesso del nascituro 133
Totale 16.498
Salva come PNG Salva come JPEG
Categoria #
all - tutte 230.068
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 230.068
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.853 0 0 0 0 0 2.051 2.153 867 1.044 359 909 470
2020/20217.786 1.066 188 699 655 926 334 966 1.038 257 1.005 356 296
2021/20226.963 130 1.273 483 459 142 334 250 390 941 573 704 1.284
2022/20236.690 972 573 365 449 1.184 1.018 125 616 891 60 225 212
2023/20244.666 201 264 198 332 1.266 515 622 569 74 59 117 449
2024/20257.008 486 186 115 1.142 3.078 2.001 0 0 0 0 0 0
Totale 59.584